Our company is currently establishing a groundbreaking collaborative framework with leading domestic research institutions. One significant partnership in this endeavor is with the Institute for Quantitative Biosciences at the University of Tokyo (hereinafter referred to as IQB). Together with IQB, we are deepening our collaboration to jointly develop, implement, and enhance our unique security system, the “IQB Gate.” This system integrates security functions with vital sign measurement capabilities, adapting to both centralized and distributed independent management to accommodate a variety of installation environments.
We have built our foundation starting with life sciences-based basic research and have accumulated significant research achievements with our proprietary technology over many years. One result of these efforts is the “IQB Gate,” a device that excels in both design and functionality.
Even before the COVID-19 pandemic, we have been individually advancing various technical elements, such as biometric recognition technology, motion detection and tracking technology, advanced encryption security technology, edge computing technology, multi-architecture adaptation, vital sign measurement technology, and biomarker measurement technology. The fusion of these elements has been recognized by prominent domestic research and medical institutions, including the IQB, as capable of producing high added value.